SANDU PHARMACEUTICALS

BSE: 524703 28 Jun 2025

Healthcare

₹ 50

Sandu Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SANDU PHARMACEUTICALS

BSE: 524703 28 Jun 2025

Healthcare

₹ 50

Sandu Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

43.5

Dividend Yield

1.58%

Debt to Equity

0.01

Stock P/E

31.5

Market Cap

48.8 Cr

SANDU PHARMACEUTICALS - Share Price & Details

Market Cap

₹48.8

High /Low

69.5 / 43.8

Stock P/E

31.5

Book Value

₹43.5

Dividend Yield

1.58

ROCE

5.44

ROE

₹3.75

Face Value

10.0

PEG Ratio

EVEBITDA

₹15.9

Debt

0.48

CMP / FCF

358.0

Debt to equity

₹0.01

NP Ann

1.55

High price all time

86.0

Piotroski score

₹7.0

Graham Number

39.6

No. Eq. Shares

0.97

Net CF

₹0.30

Net profit

1.55

Price to book value

1.16

Interest Coverage

₹22.6

Low price all time

6.14

Industry PE

32.0

Reserves

₹32.4

Free Cash Flow

₹1.93

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
LOOKS HEALTH SERVICES LIMITED	NA	NA	NA	NA	5.11	256.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
SANDU PHARMACEUTICALS LTD.	NA	NA	NA	NA	48.8	31.5
ROOPA INDUSTRIES LTD.	NA	NA	NA	NA	46.3	22.8
SHELTER PHARMA LIMITED	NA	NA	NA	NA	45.9	6.34

Peer Comparison Chart

About SANDU PHARMACEUTICALS

Sandu Pharmaceuticals Ltd., with Security Code 524703, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Has Sandu Pharma. declared dividend?

(07 Jun 2025)

Sandu Pharmaceuticals Ltd has declared an 8% dividend, amounting to ₹0.80 per share, with an ex-date of September 19, 2024. While recent total returns show...

India Ayurvedic Products Market Size & Forecast to 2033

(03 Jun 2025)

Emphasis on Product Type (Healthcare Products: Ayurvedic Medicines, Ayurvedic Nutraceuticals and Dietary Supplements; Personal Care...

Sandu Pharmaceuticals Reports Decline in Sales, Faces Financial Challenges in March 2025

(30 May 2025)

Sandu Pharmaceuticals has reported its financial results for the quarter ending March 2025, revealing net sales of Rs 14.07 crore,...

Sandu Pharmaceuticals consolidated net profit declines 44.07% in the March 2025 quarter

(29 May 2025)

Sales decline 9.81% to Rs 14.07 crore. Net profit of Sandu Pharmaceuticals declined 44.07% to Rs 0.33 crore in the quarter ended March 2025 as against Rs...

Cerebra Integrated Technologies reports consolidated net loss of Rs 7.72 crore in the March 2025 quarter

(29 May 2025)

Sales decline 83.43% to Rs 2.52 crore.

Kothari Products consolidated net profit declines 10.23% in the March 2025 quarter

(27 May 2025)

Sales decline 19.35% to Rs 222.83 crore. Net profit of Kothari Products declined 10.23% to Rs 10.27 crore in the quarter ended March 2025 as...

Quarterly Table

Standalone Consolidated

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	16.8	17.1	15.3	17.7	16.6	17.4	15.6	17.0	17.7	18.4
Expenses	15.9	16.3	14.8	17.3	15.8	16.9	15.0	16.6	16.8	17.4
Operating Profit	0.9	0.8	0.5	0.4	0.8	0.5	0.6	0.4	0.9	1.0
OPM %	5.14%	4.8%	3.16%	2.01%	4.97%	2.94%	3.88%	2.38%	5.18%	5.39%
Other Income	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2
Profit before tax	0.9	0.7	0.4	0.2	0.8	0.4	0.7	0.3	0.7	0.8
Tax %	-31.7%	-31.1%	-27.5%	-47.9%	-27.9%	-45.2%	-17.4%	-38.4%	-32.8%	-30.4%
Net Profit	0.6	0.5	0.3	0.1	0.6	0.2	0.6	0.2	0.5	0.6
EPS in Rs	0.64	0.52	0.27	0.11	0.57	0.21	0.5	0.17	0.52	0.57

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	16.8	17.1	15.3	17.7	16.6	17.4	15.6	17.0	17.7
Expenses	15.9	16.3	14.8	17.3	15.8	16.9	15.0	16.6	16.8
Operating Profit	0.9	0.8	0.5	0.4	0.8	0.5	0.6	0.4	0.9
OPM %	5.13%	4.79%	3.15%	2.01%	4.97%	2.93%	3.88%	2.38%	5.14%
Other Income	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2
Profit before tax	0.9	0.7	0.4	0.2	0.8	0.4	0.7	0.3	0.7
Tax %	-31.8%	-31%	-27.9%	-47.9%	-28%	-45.2%	-17.4%	-38.4%	-32.8%
Net Profit	0.6	0.5	0.3	0.1	0.6	0.2	0.6	0.2	0.5
EPS in Rs	0.64	0.51	0.26	0.11	0.57	0.21	0.62	0.17	1.95

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	7%
5 Years:	6%
3 Years:	5%
TTM:	3%

Compounded Profit Growth
10 Years:	11%
5 Years:	17%
3 Years:	10%
TTM:	60%

Stock Price CAGR
10 Years:	7%
5 Years:	28%
3 Years:	-9%
1 Year:	-7%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	2%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	4%

Stock Price CAGR
10 Years:	7%
5 Years:	28%
3 Years:	-9%
1 Year:	-7%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

SANDU PHARMACEUTICALS

SANDU PHARMACEUTICALS

SANDU PHARMACEUTICALS - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About SANDU PHARMACEUTICALS

Latest News

Has Sandu Pharma. declared dividend?

India Ayurvedic Products Market Size & Forecast to 2033

Sandu Pharmaceuticals Reports Decline in Sales, Faces Financial Challenges in March 2025

Sandu Pharmaceuticals consolidated net profit declines 44.07% in the March 2025 quarter

Cerebra Integrated Technologies reports consolidated net loss of Rs 7.72 crore in the March 2025 quarter

Kothari Products consolidated net profit declines 10.23% in the March 2025 quarter

Sandu Pharmaceuticals Faces Significant Volatility Amid Weak Long-Term Financial Fundamentals

Sandu Pharmaceuticals Faces Increased Volatility Amid Weak Performance Metrics and Market Trends

Live market news, research and portfolio

Goa’s iconic Tito’s planning a stock market foray via stake sale

Sandu Pharmaceuticals Hits 52-Week Low at Rs 52.6, Declines 25.21% Over Past Year

Sandu Pharmaceuticals Hits 52-Week Low at Rs 53.5, Down 24.80% Yearly

Sandu Pharmaceuticals Hits 52-Week Low at Rs. 53.5 Amid Ongoing Decline

Sandu Pharmaceuticals Reports Positive Financial Results for Q2 2024-25

Sandu Pharmaceuticals consolidated net profit declines 9.09% in the September 2024 quarter

Sandu Pharmaceuticals standalone net profit declines 9.09% in the September 2024 quarter

Sandu Pharmaceuticals standalone net profit declines 9.09% i

Vashu Bhagnani Industries consolidated net profit declines 37.50% in the September 2024 quarter

Moldova's Sandu decries 'unprecedented' meddling as EU referendum goes to wire

Sandu Pharmaceuticals Hits 52-Week Low, Receives Strong Sell Rating from MarketsMOJO

MCX, Rites among over 200 stocks to remain in focus next week for dividend, bonus, split. Do you own any?

Dividend Stocks: Kirloskar Industries, Mazagon Dock, NALCO among others to trade ex-dividend next week; Full list here | Stock Market News

Dividend Stocks: Kirloskar Industries, Mazagon Dock, NALCO among others to trade ex-dividend next week; Full list here

Sandu Pharma Consolidated June 2024 Net Sales at Rs 17.05 crore, down 3.46% Y-o-Y

Sandu Pharma Standalone June 2024 Net Sales at Rs 17.05 crore, down 3.46% Y-o-Y

Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter

Q1 Results 2024: IRFC, NMDC, Apollo Hospitals, Hero MotoCorp, Reliance Power, Hindalco, IRCTC – Key earnings to watch out for this week

Sandu Kumarvin, an Ayurvedic digestive and immunity booster for children launched by Sandu Pharmaceuticals Ltd

Sandu Pharma partners with Vavo Digital for digital influencer campaign

LENOVO INTEL SME ZONE

Stocks to watch: Hindalco, TaMo, SBI, GPT Infra, IIFL Finance | Stock Market News

Stocks to watch: Hindalco, TaMo, SBI, GPT Infra, IIFL Finance

Exploring the Top 10 Ayurvedic Brands of India: A Journey to Holistic Wellness

Sandu Pharmaceuticals Share Price

Buzzing Stocks: Wipro, RVNL, Cyient, Bajaj Fin, NHPC, Torrent Power, ITC, ICICI Bank & others

5 Best Pharma Penny Stocks in India

Buzzing Stocks: Paytm, Tata Consumer, Nykaa, Britannia, Kotak Mahindra, others in news

Beyond Three Generations: Making business future-proof | Lifestyle News | English Manorama

Why family businesses fail at succession – stubborn seniors, ‘helicopter landings’

Union minister Shripad Naik felicitated eminent Ayurvedic doctors on the occasion of Dhanvantari Pujan and National Ayurveda Day

Five Ayurvedic Doctors to be felicitated on National Ayurveda Day, Nov 11

5 city ayurveda doctors awarded for their work

Sandu Pharmaceuticals Splits: Splits, Split History, Stock Split History

Sandu Pharmaceuticals Profit Loss: Check Sandu Pharmaceuticals Profit & Loss Account Annual Statement

Sandu Pharmaceuticals Profit Loss: Check Sandu Pharmaceuticals Profit & Loss Account Interim Statement

Sandu Pharmaceuticals shines on inking MoU with Bach Ma Van Xuan Pharmaceuticals

Why are shares of JP Associates, Va Tech Wabag, JP Power, Rail Vikas Nigam and Sandu Pharma, rallying today?

Stocks that will see action on December 12, 2022

‘Har Din Har Ghar Ayurveda’- National Ayurveda Day Celebrated by Sandu Pharmaceuticals Ltd

'Har Din Har Ghar Ayurveda'- National Ayurveda Day Celebrated by Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Share Price Today - Sandu Pharmaceuticals Stock Price Live NSE/BSE

TheSmallBigIdea bags integrated digital marketing mandate for Sandu Pharmaceuticals

TheSmallBigIdea appointed as digital strategic partner for Sandu Pharmaceuticals

Sandu Pharmaceuticals reports Q1-FY2023 results

Sandu Pharmaceuticals Ltd. launches Sandu Kumarvin

Sandu Pharmaceuticals launches Sandu Kumarvin

Sandu Pharmaceuticals Ltd launches Sandu Kumarvin

Sandu Pharmaceuticals Q4FY21 PAT at Rs. 46.14 lakhs

Sandu Pharmaceuticals Limited allots 8,89,667 Equity Shares

Sandu Pharmaceuticals board approves incorporation of wholly-owned subsidiary

Union Minister Nitin Gadkari unveils Sandu’s Arogyadarshika (Health Calendar) 2022, aimed to provide Healthcare along with Mental Support amid Covid-19 pandemic

Union Minister Nitin Gadkari unveils Sandu’s Health-Calendar 2022, aimed to provide Healthcare along with Mental Support amid pandemic

Buzzing Stocks: Avenue Supermarts, Granules India, Sandu Pharma and other stocks in news today

Sandu Pharmaceuticals Ltd issued show cause notice

Quarterly Table

Shareholding Distribution

Shareholding Pattern

Compounded Data

All Deals

Select Date

Stock Mutual Funds Data